Delivery Order SPE2DB20D1109-SPE2DB23FP17J

Award Date 5/19/23
Potential Completion Date 5/22/23
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,576.73 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,828,438 units of the generic drug Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,425,639 units of Ondansetron ODT 8 mg tablets, a medication commonly used to treat nausea and vomiting. The delivery order is valued at $1,085.14 and has a firm fixed price. The contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This delivery order is likely part of a larger...
This is a $4,619.45 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 8 mg Tablets, a medication used to treat nausea and vomiting. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,075.56 firm fixed-price contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a period of performance through March 4, 2024. This order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This is a $2,577.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting, to support military healthcare programs. The contract has an ultimate completion date of February 26, 2024. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery...
This is a $1,167.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,149,344 units of the prescription medication Ondansetron ODT 4 mg Tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $20,519.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4563573519 Ondansetron ODT 4 mg Tablets 30s, and has an ultimate completion date of February 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,775.23 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg Tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a $43,984.57 delivery order (SPE2DB22D2005|SPE2DB24FJSS9) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for 4,565,804,147 units of the medication ondansetron ODT 4 mg tablet, a generic antiemetic used to prevent nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of September 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a $23,129.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,218,533 units of Ondansetron ODT 4 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows DLA to efficiently procure a wide range of medical commodities to support military treatment...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FP17J
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,041.90 firm fixed-price delivery order is for the supply of 4560995849 - Ondansetron ODT 4 MG Tablet 30S, a medication used to prevent nausea and vomiting. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order has a period of performance through May 22, 2023, supporting the medical needs of federal agencies and facilities.

Generated 2/27/25, 12:07 PM